Page last updated: 2024-08-23

fe(iii)-edta and losartan potassium

fe(iii)-edta has been researched along with losartan potassium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becquet, O; Besnard, M; Guyot, D; Kuo, P; Lapillonne, A; Papouin, M; Pawlotsky, F	1

Other Studies

1 other study(ies) available for fe(iii)-edta and losartan potassium

Article	Year
Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants. BMC pediatrics, 2013, Oct-28, Volume: 13 Topics: Anemia; Blood Transfusion; Edetic Acid; Erythropoietin; Female; Ferric Compounds; Fetal Growth Retardation; Follow-Up Studies; Gestational Age; Hemoglobins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phlebotomy; Retrospective Studies; Risk Assessment; Unnecessary Procedures	2013

Article

Year

Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants.

BMC pediatrics, 2013, Oct-28, Volume: 13

Topics: Anemia; Blood Transfusion; Edetic Acid; Erythropoietin; Female; Ferric Compounds; Fetal Growth Retardation; Follow-Up Studies; Gestational Age; Hemoglobins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phlebotomy; Retrospective Studies; Risk Assessment; Unnecessary Procedures

2013